HAMELN PHARMA LTD

Company number 01034697 · Active · Gloucester GL3 4AG

A
Firmoscan score 93/100

HAMELN PHARMA LTD is an active private limited company (company number 01034697) incorporated on 14 December 1971, registered in Gloucester. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest full accounts cover the period ending 31 December 2025, showing net assets of £13.82m and cash of £2.32m, with 32 employees on average. Turnover was £28.61m and profit for the year £2.88m. Net assets rose 26% on the prior period (£10.94m).

By net assets it sits in the top quarter of 181 comparable companies in Other (median £10k, upper quartile £324k).

Key dates

Incorporated
14 December 1971
Next accounts due
30 September 2027 — in 347 days
Confirmation statement due
28 December 2026 — in 71 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 46460
Wholesale of pharmaceutical goods
Accounts type
Full
Size band
Medium (Companies Act thresholds)

Financials — 5 periods on record, latest ending 31 December 2025

Net assets
Net assetsJan 2023: not reported; Dec 2023: £11.62m; Jan 2024: not reported; Dec 2024: £10.94m; Dec 2025: £13.82mn/a£11.62mn/a£10.94m£13.82mJan 2023Dec 2023Jan 2024Dec 2024Dec 2025
Cash at bank
Cash at bankJan 2023: not reported; Dec 2023: £3.86m; Jan 2024: not reported; Dec 2024: £2.72m; Dec 2025: £2.32mn/a£3.86mn/a£2.72m£2.32mJan 2023Dec 2023Jan 2024Dec 2024Dec 2025
Turnover
TurnoverJan 2023: not reported; Dec 2023: £24.51m; Jan 2024: not reported; Dec 2024: £27.41m; Dec 2025: £28.61mn/a£24.51mn/a£27.41m£28.61mJan 2023Dec 2023Jan 2024Dec 2024Dec 2025
Profit for the year
Profit for the yearJan 2023: not reported; Dec 2023: £2.73m; Jan 2024: not reported; Dec 2024: £2.92m; Dec 2025: £2.88mn/a£2.73mn/a£2.92m£2.88mJan 2023Dec 2023Jan 2024Dec 2024Dec 2025
Average employees
Average employeesJan 2023: not reported; Dec 2023: 29; Jan 2024: not reported; Dec 2024: 29; Dec 2025: 32n/a29n/a2932Jan 2023Dec 2023Jan 2024Dec 2024Dec 2025
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£13.82m£2.32m—£5.84m£28.61m£2.88m32
31 December 2024£10.94m£2.72m—£4.60m£27.41m£2.92m29
1 January 2024———————
31 December 2023£11.62m£3.86m—£3.29m£24.51m£2.73m29
1 January 2023———————
Current ratio
3.36 — comfortable
Net margin
10.1%
Cash per employee
£73k

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Firmoscan score: 93/100 (grade A)

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.

Ownership and control

  • Mr Christoph Kerstein — owns 75–100% of shares · since 6 April 2016
  • Mrs Beate Kueter — has significant influence or control · since 1 June 2025
  • Mr Stephen Allen Watkin — has significant influence or control · since 1 June 2025
  • Mr Stephen Allen Watkin — has significant influence or control · since 6 April 2016 · ceased 31 March 2022

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

Similar companies in the UK

Same activity (wholesale of pharmaceutical goods), closest in incorporation date.

Reminders for HAMELN PHARMA LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.